As of 12:31 PM on the 12th, Celltrion is trading at 267,500 KRW, up 2.1% from the previous day. This is a 15.88% decrease compared to September 8. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have a net purchase of 2,389 shares of Celltrion, and institutions have a net purchase of 2,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 133,906 shares, while foreigners and institutions have net sold 233,079 shares and net purchased 100,529 shares, respectively.


On October 5, Celltrion was an issue in the market as it "stalled due to news of the merger of three group companies."


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing